<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <title>LLM Context: MACROGENICS INC</title>
    <style>
        body {
            font-family: 'SF Mono', 'Monaco', 'Inconsolata', 'Fira Code', monospace;
            font-size: 13px;
            line-height: 1.5;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            background: #f5f5f5;
        }
        .header {
            background: linear-gradient(135deg, #1a1a2e 0%, #16213e 100%);
            color: white;
            padding: 20px;
            border-radius: 8px;
            margin-bottom: 20px;
        }
        .header h1 { margin: 0 0 10px 0; font-size: 18px; }
        .header .meta { opacity: 0.8; font-size: 12px; }
        .context-box {
            background: white;
            border-radius: 8px;
            padding: 0;
            overflow: hidden;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        .context-box div {
            white-space: pre;
            font-family: inherit;
        }
        .legend {
            background: #f8f9fa;
            padding: 15px;
            margin-bottom: 20px;
            border-radius: 8px;
            font-size: 12px;
        }
        .legend-item {
            display: inline-block;
            margin-right: 15px;
            padding: 3px 8px;
            border-radius: 4px;
        }
        .stats {
            margin-bottom: 15px;
            font-size: 12px;
            color: #666;
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>LLM Context View: MACROGENICS INC (MGNX)</h1>
        <div class="meta">
            This is EXACTLY what the LLM sees via to_llm_context()<br>
            Generated: 2025-12-31 18:37:36 |
            Characters: 65,916 |
            ~Tokens: 16,479
        </div>
    </div>

    <div class="legend">
        <strong>Section Colors:</strong><br>
        <span class="legend-item" style="background:#e3f2fd;">COMPANY</span>
        <span class="legend-item" style="background:#f3e5f5;">LEGEND</span>
        <span class="legend-item" style="background:#e8f5e9;">FISCAL</span>
        <span class="legend-item" style="background:#fff3e0;">CONCEPTS</span>
        <span class="legend-item" style="background:#fce4ec;">PERIODS</span>
        <span class="legend-item" style="background:#e0f2f1;">UNITS</span>
        <span class="legend-item" style="background:#f1f8e9;">DIMENSIONS</span>
        <span class="legend-item" style="background:#ede7f6;">CALCULATIONS</span>
        <span class="legend-item" style="background:#e1f5fe;">PRESENTATION</span>
        <span class="legend-item" style="background:#fff8e1;">SAMPLE FACTS</span>
        <span class="legend-item" style="background:#eceff1;">TOTALS</span>
    </div>

    <div class="context-box">
<div style="background:#e3f2fd;padding:1px 10px;margin:0;">&lt;&lt;&lt;BEGIN_XBRL_REFERENCE_DATA&gt;&gt;&gt;</div><div style="background:#e3f2fd;padding:1px 10px;margin:0;">COMPANY: MACROGENICS INC (MGNX)</div><div style="background:#e3f2fd;padding:1px 10px;margin:0;">CIK: 0001125345 | Industry: Biotechnology | Sector: Healthcare</div><div style="background:#e3f2fd;padding:1px 10px;margin:0;"></div><div style="background:#f3e5f5;padding:1px 10px;margin:0;">LEGEND:</div><div style="background:#f3e5f5;padding:1px 10px;margin:0;">• qname = unique concept identifier (e.g., us-gaap:Revenues)</div><div style="background:#f3e5f5;padding:1px 10px;margin:0;">• label = human-readable name</div><div style="background:#f3e5f5;padding:1px 10px;margin:0;"></div><div style="background:#f3e5f5;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">FISCAL CALENDAR</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">Fiscal Year End: December 31</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">Quarter Mapping (fiscal → calendar end month):</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">  FY2024: Q1→Mar24 | Q2→Jun24 | Q3→Sep24 | Q4→Dec24</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">  FY2023: Q1→Mar23 | Q2→Jun23 | Q3→Sep23 | Q4→Dec23</div><div style="background:#e8f5e9;padding:1px 10px;margin:0;"></div><div style="background:#e8f5e9;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">CONCEPTS (199 numeric, top 199 shown)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">History shows latest 10-K (annual) + 10-Q (quarterly) values for magnitude validation</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">── TOP CONCEPTS (with history for magnitude validation) ──</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:Revenues | Revenues</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.1M (10-Q, 2024-01-01→2024-03-31), $58.7M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-Sale</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $103.9M (10-Q, 2024-04-01), $128.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockholdersEquity | Stockholders&#x27; Equity Attributable to Parent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $106.2M (10-Q, 2024-04-01), $152.6M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders&#x27; Equity, Including Portion Attributable to Noncontrolling Interest</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $106.2M (10-Q, 2024-04-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $91.7M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AllocatedShareBasedCompensationExpense | Share-Based Payment Arrangement, Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.6M (10-Q, 2024-01-01→2024-03-31), $18.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation | Stock Granted, Value, Share-based Compensation, Net of Forfeitures</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-89.0K (10-Q, 2023-07-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $110.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $3.0K (10-Q, 2024-04-01), $16.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-Sale, Amortized Cost</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $103.9M (10-Q, 2024-04-01), $128.9M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $38.0K (10-Q, 2024-04-01), $22.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InterestExpense | Interest Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.1M (10-Q, 2024-01-01→2024-03-31), $1.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.0M (10-K, 2023-01-01→2023-12-31), $617.0K (10-Q, 2023-01-01→2023-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:NetIncomeLoss | Net Income (Loss) Attributable to Parent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-52.2M (10-Q, 2024-01-01→2024-03-31), $-9.1M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.5M (10-Q, 2024-01-01→2024-03-31), $18.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-29.0K (10-Q, 2024-01-01→2024-03-31), $-1.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ResearchAndDevelopmentExpense | Research and Development Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $46.0M (10-Q, 2024-01-01→2024-03-31), $166.6M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $80.4M (10-Q, 2024-04-01), $101.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 13.6M (10-Q, 2024-04-01), 12.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 263.9K (10-Q, 2023-07-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $22.8M (10-Q, 2024-04-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $56.2M (10-Q, 2024-04-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-111.0K (10-K, 2023-01-01→2023-12-31), $-111.0K (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ProceedsFromSaleOfMachineryAndEquipment | Proceeds from Sale of Machinery and Equipment</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $64.0K (10-K, 2023-01-01→2023-12-31), $64.0K (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $15.54 (10-Q, 2024-04-01), $15.11 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-Q, 2024-01-01→2024-03-31), $616.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-52.2M (10-Q, 2024-01-01→2024-03-31), $-9.1M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:EarningsPerShareDiluted | Earnings Per Share, Diluted</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-0.84 (10-Q, 2024-01-01→2024-03-31), $-0.15 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:EarningsPerShareBasic | Earnings Per Share, Basic</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-0.84 (10-Q, 2024-01-01→2024-03-31), $-0.15 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 62.3M (10-Q, 2024-01-01→2024-03-31), 61.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 62.3M (10-Q, 2024-01-01→2024-03-31), 61.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CostOfGoodsAndServicesSold | Cost of Goods and Services Sold</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $270.0K (10-Q, 2024-01-01→2024-03-31), $619.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:GeneralAndAdministrativeExpense | General and Administrative Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $14.7M (10-Q, 2024-01-01→2024-03-31), $52.2M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CostsAndExpenses | Costs and Expenses</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $62.9M (10-Q, 2024-01-01→2024-03-31), $227.0M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingIncomeLoss | Operating Income (Loss)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-53.8M (10-Q, 2024-01-01→2024-03-31), $-168.2M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-29.0K (10-Q, 2024-01-01→2024-03-31), $-1.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $14.17 (10-Q, 2024-01-01→2024-03-31), $3.83 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $3.9M (10-Q, 2024-01-01→2024-03-31), $16.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 0.00 (10-Q, 2024-01-01→2024-03-31), 0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.8M (10-Q, 2024-01-01→2024-03-31), $9.6M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3M (10-Q, 2024-01-01→2024-03-31), $5.0M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensation | Share-Based Payment Arrangement, Noncash Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.6M (10-Q, 2024-01-01→2024-03-31), $18.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInInventories | Increase (Decrease) in Inventories</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $27.0K (10-Q, 2024-01-01→2024-03-31), $-230.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInAccountsReceivable | Increase (Decrease) Receivables</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-3.1M (10-Q, 2024-01-01→2024-03-31), $-45.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-201.0K (10-Q, 2024-01-01→2024-03-31), $7.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-5.9M (10-Q, 2024-01-01→2024-03-31), $-4.8M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-1.9M (10-Q, 2024-01-01→2024-03-31), $11.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-45.6M (10-Q, 2024-01-01→2024-03-31), $-78.2M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-Sale</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $50.5M (10-Q, 2024-01-01→2024-03-31), $239.7M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds From Sale And Maturity Of Available For Sale Securities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $76.8M (10-Q, 2024-01-01→2024-03-31), $161.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.5M (10-Q, 2024-01-01→2024-03-31), $1.8M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $24.8M (10-Q, 2024-01-01→2024-03-31), $-80.1M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $248.0K (10-Q, 2024-01-01→2024-03-31), $150.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-20.6M (10-Q, 2024-01-01→2024-03-31), $-7.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $242.0K (10-Q, 2024-01-01→2024-03-31), $505.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 10.1M (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $18.58 (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 6.7M (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $21.35 (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:StockIssuedDuringPeriodValueStockPlanActivity | Stock Issued During Period Value Stock Plan Activity</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $248.0K (10-Q, 2024-01-01→2024-03-31), $247.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Allowance for Credit Loss</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-Q, 2024-04-01), $0.00 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InventoryWorkInProcess | Inventory, Work in Process, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $209.0K (10-Q, 2024-04-01), $261.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InventoryFinishedGoods | Inventory, Finished Goods, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.0M (10-Q, 2024-04-01), $960.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InventoryNet | Inventory, Net</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.2M (10-Q, 2024-04-01), $1.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.01 (10-Q, 2024-04-01), $0.01 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InventoryValuationReserves | Inventory Valuation Reserves</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3M (10-Q, 2024-04-01), $3.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $80.4M (10-Q, 2024-04-01), $101.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.2M (10-Q, 2024-04-01), $10.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:Investments | Investments</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $103.9M (10-Q, 2024-04-01), $128.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $21.3M (10-Q, 2024-04-01), $21.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AssetsCurrent | Assets, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $202.6M (10-Q, 2024-04-01), $251.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $23.2M (10-Q, 2024-04-01), $23.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherAssetsNoncurrent | Other Assets, Noncurrent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.2M (10-Q, 2024-04-01), $1.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:Assets | Assets</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $248.3M (10-Q, 2024-04-01), $298.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccountsPayableCurrent | Accounts Payable, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $10.7M (10-Q, 2024-04-01), $6.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccruedLiabilitiesCurrent | Accrued Liabilities, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $18.1M (10-Q, 2024-04-01), $24.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.1M (10-Q, 2024-04-01), $3.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LiabilitiesCurrent | Liabilities, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $55.8M (10-Q, 2024-04-01), $56.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $29.9M (10-Q, 2024-04-01), $30.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $258.0K (10-Q, 2024-04-01), $258.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:Liabilities | Liabilities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $142.1M (10-Q, 2024-04-01), $145.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CommonStockSharesAuthorized | Common Stock, Shares Authorized</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 125.0M (10-Q, 2024-04-01), 125.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CommonStockValue | Common Stock, Value, Issued</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $626.0K (10-Q, 2024-04-01), $621.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CommonStockSharesOutstanding | Common Stock, Shares, Outstanding</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 62.6M (10-Q, 2024-04-01), 62.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3B (10-Q, 2024-04-01), $1.3B (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-35.0K (10-Q, 2024-04-01), $-6.0K (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-1.2B (10-Q, 2024-04-01), $-1.1B (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LiabilitiesAndStockholdersEquity | Liabilities and Equity</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $248.3M (10-Q, 2024-04-01), $298.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.9M (10-Q, 2024-01-01→2024-03-31), $100.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:GainOnRoyaltyMonetizationArrangement | Gain on royalty monetization arrangement</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $150.9M (10-K, 2023-01-01→2023-12-31), $150.9M (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:UnrecognizedTaxBenefits | Unrecognized Tax Benefits</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherNoncashIncomeExpense | Other Noncash Income (Expense)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-Q, 2024-01-01→2024-03-31), $-423.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 12.5M (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.6M (10-Q, 2024-01-01→2024-03-31), $100.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation | Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 34.6K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-1.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-163.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.7M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:EffectiveIncomeTaxRateReconciliationDeferredTaxAdjustmentsAmount | Effective Income Tax Rate Reconciliation, Deferred Tax Adjustments, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.0M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $3.2M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $10.8M (10-K, 2022-01-01→2022-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:InterestIncomeOther | Interest Income, Other</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.0M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-7.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncomeTaxExpenseBenefit | Income tax expense (benefit)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-215.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $449.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase (Decrease) Resulting From Prior Period Tax Positions</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-4.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:IncreaseDecreaseInLeaseLiabilities | Increase (decrease) in lease liabilities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-861.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:IncreaseDecreaseInDeferredRent | Increase (Decrease) in Deferred Rent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.1M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:Depreciation | Depreciation</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.6M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:EffectiveIncomeTaxRateReconciliationDeferredStateBlendedRateAdjustmentsAmount | Effective Income Tax Rate Reconciliation, Deferred State Blended Rate Adjustments, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.8M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:ValuationAllowanceDeferredTaxAssetIncreaseAmount | Valuation Allowance, Deferred Tax Asset, Increase, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount | Effective Income Tax Rate Reconciliation, Tax Credit, Orphan Drug, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-2.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:ValuationAllowanceDeferredTaxAssetDecreaseAmount | Valuation Allowance, Deferred Tax Asset, Decrease, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 1.7M (10-Q, 2024-01-01→2024-03-31), 3.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherNonoperatingIncome | Other Nonoperating Income</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.7M (10-Q, 2024-01-01→2024-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-Based Payment Arrangement</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.4M (10-Q, 2024-01-01→2024-03-31), $306.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.9M (10-Q, 2024-04-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $-75.0K (10-Q, 2024-01-01→2024-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities | Increase Decrease In Accounts Payable And Other Operating Liabilities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.2M (10-Q, 2024-01-01→2024-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:IncreaseDecreaseInOperatingLeaseLiability | Increase (Decrease) in Operating Lease Liability</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $41.0K (10-Q, 2024-01-01→2024-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $11.04 (10-Q, 2024-01-01→2024-03-31), $9.49 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:CostOfManufacturingServices | Cost of manufacturing services</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.8M (10-Q, 2024-01-01→2024-03-31), $7.6M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $34.7M (10-Q, 2024-04-01), $19.5M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $40.3M (10-Q, 2024-04-01), $14.7M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 22.3K (10-Q, 2024-01-01→2024-03-31), 365.9K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $15.98 (10-Q, 2024-04-01), $15.59 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 12.4M (10-Q, 2024-04-01), 11.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $18.2M (10-Q, 2024-04-01), $4.5M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 8.2M (10-Q, 2024-04-01), 7.9M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $18.58 (10-Q, 2024-04-01), $18.92 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $46.4M (10-Q, 2024-04-01), $17.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $23.99 (10-Q, 2024-01-01→2024-03-31), $19.12 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $17.99 (10-Q, 2024-01-01→2024-03-31), $4.97 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $10.24 (10-Q, 2024-01-01→2024-03-31), $3.73 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 257.7K (10-Q, 2024-01-01→2024-03-31), 34.6K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 23.8K (10-Q, 2024-01-01→2024-03-31), 842.5K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">dei:EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 62.6M (10-Q, 2024-05-04), 62.4M (10-K, 2024-03-02)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $365.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:ProceedsfromStockOptionsExercisedAndESPPPurchases | ProceedsfromStockOptionsExercisedAndESPPPurchases</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.6M (10-Q, 2024-01-01→2024-03-31), $553.0K (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:NetProceedsFromSaleOfFutureRoyalties | Net proceeds from sale of future royalties</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-Q, 2024-01-01→2024-03-31), $149.7M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:NonCashInterestExpenseRecognized | Non-cash interest expense recognized</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-Q, 2024-01-01→2024-03-31), $1.4M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:OperatingLeaseNoncashExpense | Operating Lease, Noncash Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $617.0K (10-Q, 2024-01-01→2024-03-31), $3.5M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:PrincipalPaymentsOnRoyaltyMonetizationArrangement | Principal payments on royalty monetization arrangement</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $157.0K (10-K, 2023-01-01→2023-12-31), $156.0K (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeaseCost | Operating Lease, Cost</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.5M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:SubleaseIncome | Sublease Income</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.1M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LeaseCost | Lease, Cost</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.7M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:VariableLeaseCost | Variable Lease, Cost</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.3M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredRevenueCurrent | Deferred Revenue, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $21.7M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:PrepaidExpenseCurrent | Prepaid Expense, Current</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.9M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:DeferredTaxAssetsOperatingLeaseLiabilities | Deferred Tax Assets, Operating Lease Liabilities</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $9.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $7.8M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $140.7M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $33.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $68.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $33.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $17.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:Section174DeferredTaxAsset | Section 174 deferred tax asset</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $48.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:ConstructionInProgressGross | Construction in Progress, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $1.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $158.0K (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsOther | Deferred Tax Assets, Other</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $6.6M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $88.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsGross | Deferred Tax Assets, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $373.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $59.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $8.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets | Deferred Tax Liabilities, Operating Lease Right Of Use Assets</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $6.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeasePayments | Operating Lease, Payments</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.9M (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 0.12 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $2.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $8.4M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:NonCashRoyaltyRevenue | Non-cash Royalty Revenue</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $90.0K (10-Q, 2023-01-01→2023-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:LiabilityRelatedToFutureRoyalties | Liability related to future royalties</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2024-01-01), $0.00 (10-Q, 2023-10-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OtherNonoperatingExpense | Other Nonoperating Expense</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $656.0K (10-Q, 2023-01-01→2023-03-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $16.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $36.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, Payments, Due Year Three</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.2M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, Payments, Due Year Five</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $6.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:OperatingLeaseLiability | Operating Lease, Liability</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $34.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, Payments, Due after Year Five</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $46.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, Payments, Due Year Four</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.9M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, Payments, Due Year Two</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $5.1M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, Payments, Due</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $70.3M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $4.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:NumberOfOperatingSegments | Number of Operating Segments</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 1.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:OperatingLossCarryforwardsNotSubjectToLimitation | Operating Loss Carryforwards Not Subject To Limitation</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $763.0M (10-K, 2023-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $0.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 1.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:DefinedContributionPlanEmployeesContributionVestedPercentage | Defined Contribution Plan, Employees Contribution, Vested Percentage</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: 1.00 (10-K, 2023-01-01→2023-12-31)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:RightOfUseAssetAndLeaseLiabilityIncrease | Right of Use asset and Lease Liability Increase</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $14.0M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">dei:EntityPublicFloat | Entity Public Float</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $322.5M (10-K, 2024-01-01)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:ProceedsFromSaleOfFutureRoyalties | Proceeds from sale of future royalties</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $150.0M (10-K, 2023-01-01→2023-12-31), $150.0M (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">mgnx:DeferredTransactionCosts | Deferred transaction costs</div><div style="background:#fff3e0;padding:1px 10px;margin:0;">  History: $343.0K (10-K, 2023-01-01→2023-12-31), $344.0K (10-Q, 2023-01-01→2023-09-30)</div><div style="background:#fff3e0;padding:1px 10px;margin:0;"></div><div style="background:#fff3e0;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#fce4ec;padding:1px 10px;margin:0;">PERIODS (84 unique)</div><div style="background:#fce4ec;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#fce4ec;padding:1px 10px;margin:0;">Instant: 2024-05-04, 2024-04-01, 2024-03-02, 2024-01-01, 2023-11-04, 2023-10-01, 2023-08-05, 2023-07-28, 2023-07-01, 2023-06-01, 2023-05-06, 2023-04-01, 2023-03-16, 2023-03-09, 2023-03-08, 2023-03-01, 2023-01-01, 2022-10-14, 2022-10-01, 2022-08-01, 2022-07-01, 2022-04-01, 2022-02-01, 2022-01-01, 2021-10-01, 2021-06-16, 2021-01-01, 2020-01-01, 2019-01-01, 2018-06-01, 2017-11-01, 2017-06-01, 2017-05-19, 2015-11-01, 2015-09-15, 2013-11-01</div><div style="background:#fce4ec;padding:1px 10px;margin:0;">Duration: 2024-01-01→2024-03-31, 2023-10-01→2023-12-31, 2023-07-01→2023-09-30, 2023-04-01→2023-06-30, 2023-03-01→2023-03-31, 2023-01-01→2023-12-31, 2023-01-01→2023-09-30, 2023-01-01→2023-06-30, 2023-01-01→2023-03-31, 2022-11-01→2022-11-30, 2022-07-01→2022-09-30, 2022-04-01→2022-06-30, 2022-01-01→2022-12-31, 2022-01-01→2022-09-30, 2022-01-01→2022-07-31, 2022-01-01→2022-06-30, 2022-01-01→2022-03-31, 2022-01-01→2022-01-31, 2021-06-01→2021-06-30, 2021-04-01→2021-04-30, 2021-01-01→2021-12-31, 2021-01-01→2021-09-30, 2021-01-01→2021-06-30, 2020-12-01→2020-12-31, 2020-11-01→2021-12-31, 2020-11-01→2020-11-30, 2020-07-01→2022-12-31, 2020-07-01→2022-09-30, 2020-06-01→2020-06-30, 2020-01-01→2020-12-31, 2020-01-01→2020-03-31, 2019-07-01→2019-07-31, 2019-01-01→2019-12-31, 2019-01-01→2019-09-30, 2019-01-01→2019-06-30, 2019-01-01→2019-03-31, 2018-11-01→2018-11-30, 2018-05-01→2018-05-31, 2018-01-01→2024-03-31, 2018-01-01→2023-09-30, 2018-01-01→2023-03-31, 2018-01-01→2018-12-31, 2018-01-01→2018-09-30, 2018-01-01→2018-06-30, 2017-10-01→2017-10-31, 2017-05-01→2017-05-31, 2017-01-01→2018-12-31, 2010-10-01→2015-10-31</div><div style="background:#fce4ec;padding:1px 10px;margin:0;"></div><div style="background:#fce4ec;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">UNITS (8 types)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">shares (301 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">iso4217:USDshares (189 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">pure (150 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">mgnx:performanceObligation (5 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">mgnx:Molecule (4 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">iso4217:USD (2 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">mgnx:Segment (2 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">mgnx:productCandidate (1 facts)</div><div style="background:#e0f2f1;padding:1px 10px;margin:0;"></div><div style="background:#e0f2f1;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">DIMENSIONS AND MEMBERS (26 dimensions, 104 members)</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">NOTE: For matched_dimension/matched_member, output ONLY the qname (e.g., &#x27;dell:ISGMember&#x27;), not this reference format</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Research and Development Arrangement, Contract to Perform for Others, Type [Axis], total_facts=388</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteMGA012AgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteMGA012Agreement, facts=79</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:A2022GileadCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=A2022GileadCollaborationAndLicenseAgreement, facts=55</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:A2021ZaiLabAgreementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=A2021ZaiLabAgreements, facts=52</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:A2018ZaiLabCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=A2018ZaiLabCollaborationAndLicenseAgreement, facts=35</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IMabBiopharmaCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IMabBiopharmaCollaborationAndLicenseAgreement, facts=34</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ProventionPRV031Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ProventionPRV031, facts=34</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:GileadFirstResearchProgramMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=GileadFirstResearchProgram, facts=21</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ProventionPRV3279Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ProventionPRV3279, facts=15</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteMGA012ClinicalServicesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteMGA012ClinicalServices, facts=12</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:JanssenCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=JanssenCollaborationAndLicenseAgreement, facts=8</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteCommercialSupplyAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteCommercialSupplyAgreement, facts=8</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IMabBiopharmaCollaborationAndLicenseAgreementClinicalSupplyMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IMabBiopharmaCollaborationAndLicenseAgreementClinicalSupply, facts=8</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteClinicalSupplyAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteClinicalSupplyAgreement, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:BoehringerIngelheimInternationalGmbHCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=BoehringerIngelheimInternationalGmbHCollaborationAndLicenseAgreement, facts=5</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabsCollaborationAndLicenseAgreementMargetuximabMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabsCollaborationAndLicenseAgreementMargetuximab, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabsCollaborationAndLicenseAgreementTRIDENTMoleculeMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabsCollaborationAndLicenseAgreementTRIDENTMolecule, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabsCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabsCollaborationAndLicenseAgreement, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabClinicalSupplyAgreementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabClinicalSupplyAgreements, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabCollaborationAndLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabCollaborationAndLicenseAgreement, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteMGA012AgreementClinicalActivitiesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteMGA012AgreementClinicalActivities, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:StatementEquityComponentsAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Equity Components [Axis], total_facts=303</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:CommonStockMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=CommonStock, facts=116</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:AdditionalPaidInCapitalMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AdditionalPaidInCapital, facts=87</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:RetainedEarningsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RetainedEarnings, facts=50</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AociIncludingPortionAttributableToNoncontrollingInterest, facts=36</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:AccumulatedOtherComprehensiveIncomeMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AccumulatedOtherComprehensiveIncome, facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] srt:ProductOrServiceAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Product and Service [Axis], total_facts=232</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenuesFromLicenseAgreementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenuesFromLicenseAgreements, facts=53</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenuesFromCMOAgreementsMemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenuesFromCMOAgreements, facts=45</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenuesFromGrantsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenuesFromGrants, facts=20</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenueFromCollaborativeAgreementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenueFromCollaborativeAgreements, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenueFromGovernmentAgreementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenueFromGovernmentAgreements, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:ProductMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Product, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ContractManufacturingMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ContractManufacturing, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenueFromRoyalityAgreementsMemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenueFromRoyalityAgreements, facts=15</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenuesFromCMOAmendmentAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenuesFromCMOAmendmentAgreement, facts=12</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ManufacturingServicesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ManufacturingServices, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ProventionBioCMOAgreeemntMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ProventionBioCMOAgreeemnt, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:RoyaltyMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Royalty, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:RevenueFromPerformanceOfTheResearchAndDevelopmentActivitiesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RevenueFromPerformanceOfTheResearchAndDevelopmentActivities, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:FinancialInstrumentAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Financial Instrument [Axis], total_facts=210</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=USGovernmentSponsoredEnterprisesDebtSecurities, facts=84</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:CorporateDebtSecuritiesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=CorporateDebtSecurities, facts=84</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:USTreasurySecuritiesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=USTreasurySecurities, facts=42</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] srt:MajorCustomersAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=srt:MajorCustomersAxis, total_facts=179</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IncyteCorporationMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IncyteCorporation, facts=67</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ProventionBioMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ProventionBio, facts=39</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLab, facts=36</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IMabBiopharmaMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=IMabBiopharma, facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:JanssenBiotechIncMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=JanssenBiotechInc, facts=9</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabLimitedMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabLimited, facts=5</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:McKessonPlasmaBiologicsAndMcKessonSpecialtyCareDistributionLLCMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=McKessonPlasmaBiologicsAndMcKessonSpecialtyCareDistributionLLC, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ASDHealthcareAndOncologySupplyMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ASDHealthcareAndOncologySupply, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:LesLaboratoiresServierAndInstitutDeRecherchesServierServierMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=LesLaboratoiresServierAndInstitutDeRecherchesServierServier, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ImabMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Imab, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:CardinalHealthIncMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=CardinalHealthInc, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] srt:CounterpartyNameAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Counterparty Name [Axis], total_facts=157</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:GileadMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Gilead, facts=76</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:NationalInstituteOfAllergyAndInfectiousDiseasesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=NationalInstituteOfAllergyAndInfectiousDiseases, facts=30</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:SynaffixBVMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=SynaffixBV, facts=21</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:DRIHealthcareAcquisitionsLPDRIMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=DRIHealthcareAcquisitionsLPDRI, facts=21</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:BoehringerIngelheimInternationalGmbHMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=BoehringerIngelheimInternationalGmbH, facts=5</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ZaiLabsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ZaiLabs, facts=3</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:SanofiMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Sanofi, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:FairValueByMeasurementFrequencyAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Measurement Frequency [Axis], total_facts=128</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:FairValueMeasurementsRecurringMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=FairValueMeasurementsRecurring, facts=128</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:FairValueByFairValueHierarchyLevelAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Fair Value Hierarchy and NAV [Axis], total_facts=108</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:FairValueInputsLevel1Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=FairValueInputsLevel1, facts=54</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:FairValueInputsLevel2Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=FairValueInputsLevel2, facts=54</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] srt:RangeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Statistical Measurement [Axis], total_facts=80</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] srt:MaximumMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Maximum, facts=43</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] srt:MinimumMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Minimum, facts=37</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:AwardTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Award Type [Axis], total_facts=79</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:RestrictedStockUnitsRSUMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=RestrictedStockUnitsRSU, facts=74</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:EmployeeStockMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=EmployeeStock, facts=5</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:PlanNameAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Plan Name [Axis], total_facts=48</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:TwoThousandSixteenEmployeeStockPurchasePlanMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=TwoThousandSixteenEmployeeStockPurchasePlan, facts=26</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:StockIncentivePlan2013Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=StockIncentivePlan2013, facts=12</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:StockIncentivePlan2023MemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=StockIncentivePlan2023, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:EquityIncentivePlan2003Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=EquityIncentivePlan2003, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:A2003StockIncentivePlanMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=A2003StockIncentivePlan, facts=1</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:SubsidiarySaleOfStockAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Sale of Stock [Axis], total_facts=44</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:AtTheMarketOfferingMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AtTheMarketOffering, facts=44</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:FairValueByAssetClassAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Asset Class [Axis], total_facts=36</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:MoneyMarketFundsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=MoneyMarketFunds, facts=36</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:IncomeStatementLocationAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Income Statement Location [Axis], total_facts=36</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:ResearchAndDevelopmentExpenseMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ResearchAndDevelopmentExpense, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:GeneralAndAdministrativeExpenseMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=GeneralAndAdministrativeExpense, facts=18</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:PropertyPlantAndEquipmentByTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:PropertyPlantAndEquipmentByTypeAxis, total_facts=32</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:ComputerEquipmentMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ComputerEquipment, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=SoftwareAndSoftwareDevelopmentCosts, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:FurnitureAndOfficeEquipmentMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=FurnitureAndOfficeEquipment, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:VehiclesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Vehicles, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:EquipmentMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Equipment, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:LeaseholdImprovementsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=LeaseholdImprovements, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:FurnitureAndFixturesMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=FurnitureAndFixtures, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:LaboratoryAndOfficeEquipmentMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=LaboratoryAndOfficeEquipment, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:ConcentrationRiskByTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:ConcentrationRiskByTypeAxis, total_facts=30</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:CustomerConcentrationRiskMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=CustomerConcentrationRisk, facts=30</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:ConcentrationRiskByBenchmarkAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:ConcentrationRiskByBenchmarkAxis, total_facts=30</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:SalesRevenueNetMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=SalesRevenueNet, facts=19</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:AccountsReceivableMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AccountsReceivable, facts=11</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis, total_facts=28</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ExercisePriceRangeFromDollars094To500MemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ExercisePriceRangeFromDollars094To500, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ExercisePriceRangeFromDollars501To1500MemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ExercisePriceRangeFromDollars501To1500, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ExercisePriceRangeFromDollars1501To2500MemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ExercisePriceRangeFromDollars1501To2500, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ExercisePriceRangeFromDollars2501To4021MemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ExercisePriceRangeFromDollars2501To4021, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:TypeOfArrangementAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:TypeOfArrangementAxis, total_facts=24</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:AssetPurchaseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=AssetPurchaseAgreement, facts=16</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ProventionLicenseAgreementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ProventionLicenseAgreement, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=CollaborativeArrangementTransactionWithPartyToCollaborativeArrangement, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] ecd:IndividualAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=Individual [Axis], total_facts=19</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:ThomasSpitznagelMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=ThomasSpitznagel, facts=7</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:JamesKarrelsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=JamesKarrels, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:JeffreyPetersMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=JeffreyPeters, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:StatementClassOfStockAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:StatementClassOfStockAxis, total_facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:UndesignatedPreferredStockMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=UndesignatedPreferredStock, facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:ValuationAllowancesAndReservesTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:ValuationAllowancesAndReservesTypeAxis, total_facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:InventoryValuationReserveMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=InventoryValuationReserve, facts=14</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:IncomeTaxAuthorityAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:IncomeTaxAuthorityAxis, total_facts=11</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:DomesticTaxAuthorityandStateandLocalJurisdictionMemberMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=DomesticTaxAuthorityandStateandLocalJurisdiction, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:DomesticCountryMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=DomesticCountry, facts=5</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis, total_facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:StockOptionsAndRestrictedStockUnitsMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=StockOptionsAndRestrictedStockUnits, facts=6</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:SubsequentEventTypeAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:SubsequentEventTypeAxis, total_facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] us-gaap:SubsequentEventMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=SubsequentEvent, facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">[DIM] us-gaap:TaxPeriodAxis</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      label=us-gaap:TaxPeriodAxis, total_facts=4</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:TaxYear2025To2037Member</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=TaxYear2025To2037, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">      [MEMBER] mgnx:IndefiniteMember</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">               label=Indefinite, facts=2</div><div style="background:#f1f8e9;padding:1px 10px;margin:0;"></div><div style="background:#f1f8e9;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">CALCULATIONS (22 formulas) - how values sum</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">Format: [Statement] Result = +adds −subtracts</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[IncomeStatement] us-gaap:DeferredTaxAssetsGross | Deferred Tax Assets, Gross = +us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic +us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local +us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research +us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other +mgnx:DeferredTaxAssetsOperatingLeaseLiabilities | Deferred Tax Assets, Operating Lease Liabilities +5more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[IncomeStatement] us-gaap:IncomeTaxExpenseBenefit | Income tax expense (benefit) = +us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount +us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount +mgnx:EffectiveIncomeTaxRateReconciliationDeferredTaxAdjustmentsAmount | Effective Income Tax Rate Reconciliation, Deferred Tax Adjustments, Amount −us-gaap:IncomeTaxReconciliationTaxCreditsResearch | Income Tax Reconciliation Tax Credits Research −us-gaap:IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount +3more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[IncomeStatement] us-gaap:DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross = +us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment +mgnx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets | Deferred Tax Liabilities, Operating Lease Right Of Use Assets +us-gaap:DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[IncomeStatement] us-gaap:DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance = +us-gaap:DeferredTaxAssetsGross | Deferred Tax Assets, Gross −us-gaap:DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[BalanceSheet] us-gaap:StockholdersEquity | Stockholders&#x27; Equity Attributable to Parent = +us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax +us-gaap:RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) +us-gaap:AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock +us-gaap:CommonStockValue | Common Stock, Value, Issued +us-gaap:CommonStockValue | Common stock, value issued +2more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[BalanceSheet] us-gaap:AssetsCurrent | Assets, Current = +us-gaap:InventoryNet | Inventory, Net +us-gaap:Investments | Investments +us-gaap:PrepaidExpenseCurrent | Prepaid Expense, Current +us-gaap:AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current +us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value +2more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[BalanceSheet] us-gaap:Liabilities | Liabilities = +us-gaap:LiabilitiesCurrent | Liabilities, Current +us-gaap:OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent +us-gaap:OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent +us-gaap:DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent +mgnx:LiabilityRelatedToFutureRoyalties | Liability related to future royalties +1more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[BalanceSheet] us-gaap:LiabilitiesCurrent | Liabilities, Current = +us-gaap:OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current +us-gaap:DeferredRevenueCurrent | Deferred Revenue, Current +us-gaap:AccruedLiabilitiesCurrent | Accrued Liabilities, Current +us-gaap:AccountsPayableCurrent | Accounts Payable, Current +us-gaap:ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[CashFlows] us-gaap:NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities = +us-gaap:NetIncomeLoss | Net Income (Loss) Attributable to Parent +us-gaap:DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization −us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments +us-gaap:ShareBasedCompensation | Share-Based Payment Arrangement, Noncash Expense −us-gaap:OtherNoncashIncomeExpense | Other Noncash Income (Expense) +15more</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[CashFlows] us-gaap:NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities = +us-gaap:ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock +mgnx:ProceedsfromStockOptionsExercisedAndESPPPurchases | Proceeds from Stock Options Exercised And ESPP Purchases +mgnx:ProceedsfromStockOptionsExercisedAndESPPPurchases | ProceedsfromStockOptionsExercisedAndESPPPurchases −us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-Based Payment Arrangement +mgnx:NetProceedsFromSaleOfFutureRoyalties | Net proceeds from sale of future royalties</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[CashFlows] us-gaap:NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities = −us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-Sale +us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds From Sale And Maturity Of Available For Sale Securities −us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[CashFlows] us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect = +us-gaap:NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities, Continuing Operations +us-gaap:NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities, Continuing Operations +us-gaap:NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities, Continuing Operations</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[ComprehensiveIncome] us-gaap:NetIncomeLoss | Net Income (Loss) Attributable to Parent = +us-gaap:OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) +us-gaap:OperatingIncomeLoss | Operating Income (Loss) +us-gaap:OtherNonoperatingIncome | Other Nonoperating Income −us-gaap:OtherNonoperatingExpense | Other Nonoperating Expense</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[ComprehensiveIncome] us-gaap:ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent = +us-gaap:NetIncomeLoss | Net Income (Loss) Attributable to Parent +us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax +us-gaap:NetIncomeLoss | Net Income (Loss) +us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | Net unrealized gains (losses) on available-for-sale securities, net of tax</div><div style="background:#ede7f6;padding:1px 10px;margin:0;">[ComprehensiveIncome] us-gaap:CostsAndExpenses | Costs and Expenses = +us-gaap:CostOfGoodsAndServicesSold | Cost of product revenues +mgnx:CostOfManufacturingServices | Cost of manufacturing services +us-gaap:ResearchAndDevelopmentExpense | Research and Development Expense +us-gaap:GeneralAndAdministrativeExpense | General and Administrative Expense</div><div style="background:#ede7f6;padding:1px 10px;margin:0;"></div><div style="background:#ede7f6;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">PRESENTATION (99 sections) - display groupings</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">────────────────────────────────────────────────────────────────────────</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[IncomeStatement]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Components of Deferred Tax Ass... (13): mgnx:DeferredTaxAssetsOperatingLeaseLiabilities | Deferred Tax Assets, Operating Lease Liabilities, us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic, us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local, us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research +9more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Components of Deferred Tax Lia... (5): us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment, mgnx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets | Deferred Tax Liabilities, Operating Lease Right Of Use Assets, us-gaap:DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses, us-gaap:DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross +1more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Income Tax Examination (4): mgnx:OperatingLossCarryforwardsNotSubjectToLimitation | Operating Loss Carryforwards Not Subject To Limitation, us-gaap:CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit), us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate, us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[BalanceSheet]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Liabilities, Current (7): us-gaap:LiabilitiesCurrent | Liabilities, Current, us-gaap:OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current, us-gaap:DeferredRevenueCurrent | Deferred Revenue, Current, us-gaap:AccruedLiabilitiesCurrent | Accrued Liabilities, Current +3more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Assets, Current (7): us-gaap:InventoryNet | Inventory, Net, us-gaap:Investments | Investments, us-gaap:AssetsCurrent | Assets, Current, us-gaap:PrepaidExpenseCurrent | Prepaid Expense, Current +3more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Liabilities and Equity (6): us-gaap:Liabilities | Liabilities, us-gaap:OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent, us-gaap:OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent, us-gaap:LiabilitiesAndStockholdersEquity | Liabilities and Equity +2more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[CashFlows]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Increase (Decrease) in Operati... (13): us-gaap:IncreaseDecreaseInAccountsReceivable | Increase (Decrease) Receivables, us-gaap:IncreaseDecreaseInInventories | Increase (Decrease) in Inventories, us-gaap:IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense, us-gaap:IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets +9more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Adjustments to Reconcile Net I... (9): us-gaap:DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization, us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments, us-gaap:ShareBasedCompensation | Share-Based Payment Arrangement, Noncash Expense, us-gaap:OtherNoncashIncomeExpense | Other Noncash Income (Expense) +5more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Net Cash Provided by (Used in)... (6): us-gaap:ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock, mgnx:ProceedsfromStockOptionsExercisedAndESPPPurchases | ProceedsfromStockOptionsExercisedAndESPPPurchases, us-gaap:NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities, mgnx:PrincipalPaymentsOnRoyaltyMonetizationArrangement | Principal payments on royalty monetization arrangement +2more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[Equity]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Increase (Decrease) in Stockho... (11): us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders&#x27; Equity, Including Portion Attributable to Noncontrolling Interest, us-gaap:NetIncomeLoss | Net Income (Loss) Attributable to Parent, us-gaap:StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues, us-gaap:StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues +7more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Statement (9): us-gaap:UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments, us-gaap:StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues, us-gaap:StockholdersEquity | Stockholders&#x27; Equity Attributable to Parent, us-gaap:StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues +5more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Class of Stock (5): us-gaap:CommonStockSharesAuthorized | Common Stock, Shares Authorized, us-gaap:CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share, us-gaap:ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock, us-gaap:ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised +1more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[Cover]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Document and Entity Informatio... (36): dei:LocalPhoneNumber | Local Phone Number, dei:Security12bTitle | Title of 12(b) Security, dei:TradingSymbol | Trading Symbol, dei:SecurityExchangeName | Security Exchange Name +32more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Cover (35): dei:EntityEmergingGrowthCompany | Entity Emerging Growth Company, dei:EntitySmallBusiness | Entity Small Business, dei:EntityFilerCategory | Entity Filer Category, dei:EntityInteractiveDataCurrent | Entity Interactive Data Current +31more</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">[Notes]</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;">  Antidilutive Securities Exclud... (1): us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</div><div style="background:#e1f5fe;padding:1px 10px;margin:0;"></div><div style="background:#eceff1;padding:1px 10px;margin:0;">TOTALS: 3,625 facts | 401 concepts | 84 periods</div><div style="background:#eceff1;padding:1px 10px;margin:0;">&lt;&lt;&lt;END_XBRL_REFERENCE_DATA&gt;&gt;&gt;</div>
    </div>

    <div style="text-align: center; color: #999; padding: 20px; font-size: 11px;">
        XBRL Catalog - Exact LLM Context View
    </div>
</body>
</html>
